EssilorLuxottica receives FDA authorization for its Essilor Stellest lens for myopia control
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
The company plans a phased expansion across India, focusing initially on metro cities and early-adoption hubs
New acetabular system enhances precision, stability and robotic compatibility in total hip arthroplasty
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
Collaboration to drive diagnostics exports, tap high-growth regional markets and build scalable commercialization platform
New appointments bring diagnostics and medtech expertise to strengthen healthcare delivery and policy engagement
The deal signals a clear push to expand access to care in underserved regions
Subscribe To Our Newsletter & Stay Updated